Jul20
Open Commission Meeting - July 20, 2023
-
Business Before the Commission: Statement Withdrawing Prior PBM Advocacy and Staff Presentation on Military Consumer Protection Efforts
Displaying 1581 - 1596 of 1596
Feb17
Open Commission Meeting - February 17, 2022
-
Business Before the Commission: 6(b) Study on Pharmacy Benefit Managers’ (PBMs) Relationship with Affiliated and Independent Pharmacies and Advanced Notice of Proposed Rulemaking Concerning Earnings...
Competition Matters
Physician Group and Healthcare Facility Merger Study
Date
On January 14, 2020, the Federal Trade Commission (FTC) ordered six insurance companies to provide information that will allow the agency to study the effects of consummated physician group and...
Business Blog
A prescription for complying with the Eyeglass Rule
Date
When patients leave the office after an appointment with their eyecare professional, they should have certain things in hand: their coat, their phone – and a copy of their eyeglass prescription. The...
Competition Matters
MMA Reports: No tricks or treats—just facts
Date
With the passage of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), Congress required pharmaceutical companies to file certain patent settlement agreements with the...
Competition Matters
Then, now, and down the road: Trends in pharmaceutical patent settlements after FTC v. Actavis
Date
Last week, Bureau of Competition staff published a report on filings received in fiscal year (FY) 2016 under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), the...
Advanced Page
Health Care Competition
The FTC’s Health Care Work When health care markets are competitive, consumers benefit from lower costs, better care and more innovation. The Federal Trade Commission enforces the antitrust laws in...
Competition Matters
Control no longer controlling for HSR reporting of not-for-profit combinations
Date
The PNO routinely provides informal guidance on Hart-Scott-Rodino reporting obligations that arise when combining not-for-profit entities, typically in the context of hospital combinations. In the...
Competition Matters
Insights into contact lenses: FTC workshop will focus on the Contact Lens Rule
Date
The FTC is eyeing its Contact Lens Rule and has announced the agenda for a March 7, 2018 workshop, The Contact Lens Rule and the Evolving Contact Lens Marketplace. The Contact Lens Rule, in place...
Competition Matters
Quo Vadis Post-Actavis?
Date
For more than 15 years, one of the FTC’s top priorities has been to put an end to anticompetitive reverse-payment settlements between brand-name drug makers and their potential generic rivals. In our...
Competition Matters
Antitrust Violation vs. Injury-in-Fact: A distinction that makes a difference
Date
There is a basic but important difference between antitrust cases brought by the government and those brought by private parties: All plaintiffs, including government enforcers like the FTC, must...
Competition Matters
Is FTC v. Actavis Causing Pharma Companies to Change Their Behavior?
Date
Since 2004, brand-name and generic drug manufacturers have filed certain agreements with the FTC and DOJ as required by the Medicare Prescription Drug, Improvement and Modernization Act (also known as...
Competition Matters
From the antitrust mailbag: What can the FTC do about prescription drug price spikes?
Date
Consumers frequently contact the Bureau of Competition to alert us that the cost of a prescription drug suddenly spiked up, and ask if the FTC can take antitrust action to bring the price back down...
Competition Matters
Power shopping for an alternative buyer
Date
In recent investigations of hospital mergers, the merging parties often make the argument that the acquired firm is flailing, if not outright failing. Thus, the argument goes, the transaction is...
Basic page
Pharmaceutical Agreement Filings
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 requires that brand-name drug manufacturers and generic drug applicants file certain agreements with the FTC and the...
Advanced Page
Competition in the Health Care Marketplace
Competition in health care markets benefits consumers because it helps contain costs, improve quality, and encourage innovation. The Federal Trade Commission's job as a law enforcer is to stop firms...
Displaying 1581 - 1596 of 1596